Clinical trial · Observational
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples.
NCT04081194CI-TRIAL-00040653unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Cell Free Circulating Nucleic Acids as New Tumor Diagnostics From Human Plasma Samples.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| New Tumor Diagnostics From Human Plasma Samples | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (2)
- label
- case group, Melanoma Patients
- description
- 15 patients of with Melanoma, Age between 40 and 90 years. -Withdrawal of Blood sample, Isolation of Exosomes: 1. Bradford protein assay And Qubit protein assay. 2. Bioanalyzer. 3. Real time PCR.
- label
- control group
- description
- 10 Persons without Melanoma, age \> 40 years -Withdrawal of Blood sample, Isolation of Exosomes: 1. Bradford protein assay And Qubit protein assay. 2. Bioanalyzer. 3. Real time PCR.
Primary outcomes (1)
- measure
- Isolation of Exosomes as a stable source of nucleic acid as an early Detection Method to diagnose Melanoma.
- timeFrame
- one year
- description
- Real time PCR for detecting the presence of Melanoma relevant nucleic acids isolated of Exososmes.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * patients with Melanoma Exclusion Criteria: * patients with other types of malignancies
References
Publications (0)
Data not yet available
No reference posted for this study.